Total planned funding: $37,653,449
Allocations
Countries/Regions
| Central Asia Region | $37,653,449 |
Organizational Types
| Own Agency | $12,276,999 |
| University | $6,464,743 |
| NGO | $6,189,169 |
| Unknown | $4,892,788 |
| Host Country Government Agency | $4,067,621 |
| Private Contractor | $2,232,129 |
| Multi-lateral Agency | $1,240,000 |
| Implementing Agency | $167,000 |
| Other USG Agency | $123,000 |
Program Areas
| Prevention | $14,822,848 |
| Management and Operations | $9,720,321 |
| Governance and Systems | $6,094,780 |
| Treatment | $3,030,584 |
| Care | $2,247,244 |
| Testing | $1,737,672 |
Budget Codes
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $10,513,488 |
| HVMS: Management and Operations | $9,720,321 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $3,322,252 |
| HTXS: Treatment: Adult Treatment | $2,997,415 |
| HLAB: Laboratory Infrastructure | $2,755,428 |
| HVSI: Strategic Information | $2,217,057 |
| HBHC: Care: Adult Care and Support | $2,124,629 |
| HVCT: Testing: HIV Testing and Counseling | $1,737,672 |
| OHSS: Health Systems Strengthening | $1,122,295 |
| HMBL: Biomedical Prevention: Blood Safety | $699,289 |
| HMIN: Biomedical Prevention: Injection Safety | $287,819 |
| HVTB: Care: TB/HIV | $122,615 |
| HTXD: Treatment: ARV Drugs | $33,169 |
Top Partner Programs
USG Aggregated Agencies:
$6,499,999
Countries/Regions
Central Asia Region
| 2011 | $5,099,999 |
| 2017 | $1,400,000 |
Columbia University:
$6,464,743
Countries/Regions
Central Asia Region
| 2011 | $927,743 |
| 2013 | $2,374,000 |
| 2017 | $3,163,000 |
Population Services International:
$5,312,378
Countries/Regions
Central Asia Region
| 2011 | $3,310,994 |
| 2013 | $0 |
| 2017 | $2,001,384 |
U.S. Centers for Disease Control and Prevention:
$3,238,500
Countries/Regions
Central Asia Region
| 2013 | $3,238,500 |